Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Gilead
 More »

  • HIV Researchers Seek a Potential Cure
    ... Gilead Sciences received European Union approval in May 2013 for Stribild® FDC, a single-tablet, fixed-dose-formulation, combination therapeutic. The company has submitted ...
    10-1-2013
  • Top 40 Molecular Millionaires
    ... The CEOs of two other pharma giants-Joseph Jimenez of Novartis, and Ian C. Read of Pfizer-narrowly missed the top 40. #10. John C. Martin Chairman and CEO, Gilead Sciences Total ...
    9-19-2013
  • Top Biotech & Pharma Companies
    This compares to 11 companies raising $771 million during the same period a year ago. Earlier this year, Burrill pointed out that Big Biotech firms (e.g., Amgen, Gilead Sciences, ...
    9-1-2013
  • FDA Approves Viiv Healthcare's HIV-1 Treatment Tivicay
    patients; another comparing once-daily Tivicay and abacavir/lamivudine to Gilead Sciences' once-daily Atripla® (efavirenz/emtricitabine/tenofovir disoproxil ...
    8-13-2013
  • The 20 Top Paid Women Executives in Biopharma
    ... 2011 Compensation: $2,535,033 % Change: 36.1% #9. Robin L. Washington Company: Gilead Sciences Title: SVP and CFO 2012 Compensation: $4,175,593 2011 Compensation: ...
    8-5-2013
  • Creative Acquisition in Biotech, Take Two
    in 2012 were, in descending order: Amgen, Gilead Sciences, Biogen Idec, Celgene, Vertex ... Two more examples should suffice: First, Gilead Sciences, which acquired Pharmasset in ...
    8-1-2013
  • What the Top 15 Biopharma CEOs Are Making
    ... $16,370,094 % Change: -10.7% Position on 2012 List: #5 #6. John C. Martin Company: Gilead Sciences Full title: Chairman of the Board and CEO 2012 Compensation: $15,257,272 2011 ...
    7-31-2013
  • Adimab Licenses Antibody Platform to GSK, Biogen Idec
    ... In addition to Biogen Idec and GSK, Adimab's partners include Merck, Roche, Novartis, Eli Lilly, Genentech, Novo Nordisk, Human Genome Sciences, Gilead, and Kyowa Hakko Kirin. ...
    7-26-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    Right behind Novo Nordisk is Amgen (NASDAQ:AMGN) with a $78.7 billion market cap, Gilead ... Pharmaceuticals (NASDAQ:VRTX), and especially Gilead, which nearly tripled its market cap. ...
    7-25-2013
  • Top 25 Biotech Companies of 2013
    Vertex Pharmaceuticals, and especially Gilead Sciences, which nearly tripled its market ... 53.1% Position on 2012 List: #7 #3. Gilead Sciences 2013 Market Cap: $78.373 billion ...
    7-15-2013
  • High-Tech Academic Centers Look to Milk Their Cash Cows
    told GEN. One of those successes is Gilead Sciences' HIV drug Emtriva ... to Triangle Pharmaceuticals, acquired by Gilead in 2003, the year FDA first approved ...
    7-1-2013
  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and ... And Gilead Sciences also announced results from a Phase II study, a trial evaluating its ...
    5-16-2013
  • Biotechs Need to Walk the Walk on Drug Value
    ... Another precompetitive effort, DILI-sim Initiative, joins the Hamner Institutes for Health Sciences with 12 drug developers-Amgen, AZ, BMS, Eli Lilly, Gilead, Glaxo, Janssen, ...
    5-15-2013
  • GEN | Biolinks
    ... Georgetown University Georgia Bio Georgia Department of Economic Development Geron Gilead Sciences Gilson GlaxoSmithKline Global Alliance for TB Drug Development GlobeImmune ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... Another precompetitive effort, DILI-sim Initiative, joins the Hamner Institutes for Health Sciences with 12 drug developers-Amgen, AZ, BMS, Eli Lilly, Gilead, Glaxo, Janssen, ...
    4-22-2013

  • Journal Articles

  • The Balm of Gilead Project: A Demonstration Project on End-of...
    Elizabeth A. Kvale, Beverly R. Williams, James L. Bolden, Carol G. Padgett, F. Amos Bailey
    Journal of Palliative Medicine
    The Balm of Gilead Project: A Demonstration Project on End-of-Life Care for Safety-Net Populations Journal of Palliative Medicine The Balm of Gilead is a comprehensive program of ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll